Aiklu Investors

Aiklu was founded in 2019 to build and deploy Artificial Intelligence directly in to the lives of patients. In spite of Covid we managed a successful fund raise, an Innovate UK grant fund, CQC approval for Clinics, Nationwide Telehealth services with our secure apps and now a Global launch of our Skin Services.

Headquarters: London, England, United Kingdom
Industry: Healthcare Company
Technology: NeuroTech Augmentation (Tech and Pharma)